Krystal Biotech KRYS

$ 182.38 2.4%

Quarterly report 2024-Q3
added 11-04-2024

Krystal Biotech EV/EBITDA Ratio 2011-2024 | KRYS

Annual EV/EBITDA Ratio Krystal Biotech

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-16.6	-35.4	-30.6	-12.9	-0.89	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.89	-35.4	-19.3